Schedule of quarterly financial information |
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2020
|
|
|
As Previously
|
|
Restatement
|
|
|
|
|
|
Reported
|
|
Adjustment
|
|
As Restated
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
216,445,723
|
|
$
|
—
|
|
$
|
216,445,723
|
Liabilities and shareholders’ equity
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
$
|
161,956
|
|
$
|
—
|
|
$
|
161,956
|
Deferred legal fees
|
|
|
—
|
|
|
|
|
|
|
Deferred underwriting commissions
|
|
|
7,525,000
|
|
|
—
|
|
|
7,525,000
|
Derivative warrant liabilities
|
|
|
—
|
|
|
16,197,500
|
|
|
16,197,500
|
Total liabilities
|
|
|
7,686,956
|
|
|
16,197,500
|
|
|
23,884,456
|
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption
|
|
|
203,758,760
|
|
|
(16,197,500)
|
|
|
187,561,260
|
Shareholders’ equity
|
|
|
|
|
|
|
|
|
|
Preference shares - $0.0001 par value
|
|
|
—
|
|
|
—
|
|
|
—
|
Class A ordinary shares - $0.0001 par value
|
|
|
112
|
|
|
162
|
|
|
274
|
Class B ordinary shares - $0.0001 par value
|
|
|
538
|
|
|
—
|
|
|
538
|
Additional paid-in-capital
|
|
|
5,190,381
|
|
|
601,798
|
|
|
5,792,179
|
Accumulated deficit
|
|
|
(191,024)
|
|
|
(601,960)
|
|
|
(792,984)
|
Total shareholders’ equity
|
|
|
5,000,007
|
|
|
—
|
|
|
5,000,007
|
Total liabilities and shareholders’ equity
|
|
$
|
216,445,723
|
|
$
|
—
|
|
$
|
216,445,723
|
|
|
|
|
|
|
|
|
|
|
|
|
Period From June 24, 2020 (Inception) Through September 30, 2020
|
|
|
As Previously
|
|
Restatement
|
|
|
|
|
|
Reported
|
|
Adjustment
|
|
As Restated
|
|
|
|
|
|
|
|
|
|
|
Unaudited Condensed Statement of Operations
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
$
|
(201,002)
|
|
$
|
—
|
|
$
|
(201,002)
|
Other (expense) income:
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liabilities
|
|
|
—
|
|
|
—
|
|
|
—
|
Offering costs associated with derivative warrant liabilities
|
|
|
—
|
|
|
(601,960)
|
|
|
(601,960)
|
Net gain from investments held in Trust Account
|
|
|
9,978
|
|
|
—
|
|
|
9,978
|
Total other (expense) income
|
|
|
9,978
|
|
|
(601,960)
|
|
|
(591,982)
|
Net loss
|
|
$
|
(191,024)
|
|
$
|
(601,960)
|
|
$
|
(792,984)
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted weighted-average Class A ordinary shares outstanding
|
|
|
21,500,000
|
|
|
—
|
|
|
21,500,000
|
Basic and Diluted net loss per Class A share
|
|
$
|
0.00
|
|
|
—
|
|
$
|
0.00
|
Basic and Diluted weighted-average Class B ordinary shares outstanding
|
|
|
5,162,280
|
|
|
—
|
|
|
5,162,280
|
Basic and Diluted net loss per Class B share
|
|
$
|
(0.04)
|
|
|
—
|
|
$
|
(0.16)
|
|
|
|
|
|
|
|
|
|
|
|
|
Period From June 24, 2020 (Inception) Through September 30, 2020
|
|
|
As Previously
|
|
Restatement
|
|
|
|
|
|
Reported
|
|
Adjustment
|
|
As Restated
|
|
|
|
|
|
|
|
|
|
|
Unaudited Condensed Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(191,024)
|
|
$
|
(601,960)
|
|
$
|
(792,984)
|
Offering costs associated with derivative warrant liabilities
|
|
|
—
|
|
|
601,960
|
|
|
601,960
|
Net cash used in operating activities
|
|
|
(393,915)
|
|
|
—
|
|
|
(393,915)
|
Net cash used in investing activities
|
|
|
(215,000,000)
|
|
|
—
|
|
|
(215,000,000)
|
Net cash provided by financing activities
|
|
|
216,459,791
|
|
|
—
|
|
|
216,459,791
|
Net change in cash
|
|
$
|
1,065,876
|
|
$
|
—
|
|
$
|
1,065,876
|
|